Lenoir, NC September 18, 2017 – Exela Pharma Sciences today announced that it began shipments of its FDA approved Ganciclovir Injection in 0.8% sodium chloride solution on September 18, 2017 to wholesalers across the country. Ganciclovir Injection is indicated for the treatment of cytomegalovirus (CMV) retinitis in immunocompromised adult patients, including patients with acquired immunodeficiency syndrome (AIDS) and for the prevention of CMV disease in adult transplant recipients at risk for CMV disease. Ganciclovir carries a boxed warning. Please see safety information below and additional important safety information in the full prescribing information by clicking here. Exela’s Ganciclovir Injection is
Read More

WINSTON-SALEM, NC – The North Carolina Manufacturing Extension Partnership (NCMEP), a public-private operating alliance working to help manufacturing companies become operationally efficient and well positioned to grow profitably, today announced the winners of its 2017 Manufacturing Leadership Awards at mfgCON in Winston-Salem, North Carolina. The state awards program recognizes manufacturers for their commitment to the North Carolina manufacturing sector, as proven by outstanding performance in the areas of Innovation, Sustainable Manufacturing, Advanced Talent Development, Developing Markets and Continuous Improvement. “Our state’s manufacturers continue to expand and excel in performance, leading to sustained customer satisfaction,” says Phil Mintz, NCMEP Director and Executive
Read More